GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oryzon Genomics SA (STU:ORN) » Definitions » Price-to-Funds-From-Operations

Oryzon Genomics (STU:ORN) Price-to-Funds-From-Operations : (As of Jun. 10, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Oryzon Genomics Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Oryzon Genomics (STU:ORN) Business Description

Industry
Traded in Other Exchanges
Address
Sant Ferran 74, Cornellà de Llobregat, Barcelona, ESP, 08940
Oryzon Genomics SA is a clinical stage biopharmaceutical company and engaged in the development of epigenetics-based therapeutics. It is engaged in the field of epigenetic medicine and in the development of therapeutic, biological solutions for cancer and neurodegenerative diseases.